Omeros Corp. (OMER) PT Raised to $34 at H.C. Wainwright ON Priority Review of Narsoplimab
Tweet Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju raised the price target on Omeros Corp. (NASDAQ: OMER) to $34.00 (from $31.00) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
